Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,029 | 1,481 | 39,139 | -148,701 | -127,761 |
| Depreciation Amortization | 5,557 | 3,692 | 1,832 | 7,190 | 5,382 |
| Accounts receivable | -898 | -214 | -308 | N/A | N/A |
| Accounts payable and accrued liabilities | 5,134 | 2,147 | 653 | -1,962 | 475 |
| Other Working Capital | -15,083 | -10,962 | -9,564 | 311 | 2,812 |
| Other Operating Activity | -57,599 | -51,158 | -60,353 | 45,040 | 47,547 |
| Operating Cash Flow | $-78,918 | $-55,014 | $-28,601 | $-98,122 | $-71,545 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -845 | -796 | -228 | -1,572 | -1,509 |
| Investing Cash Flow | $-845 | $-796 | $-228 | $-1,572 | $-1,509 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 20,000 | 20,000 |
| Debt Repayment | -2,157 | -1,414 | -687 | -2,579 | -1,906 |
| Common Stock Issued | 56,856 | 50,659 | 47,426 | 97,372 | 45,693 |
| Other Financing Activity | -50,385 | -340 | 0 | -610 | -610 |
| Financing Cash Flow | $4,314 | $48,905 | $46,739 | $114,183 | $63,177 |
| Beginning Cash Position | 95,290 | 95,290 | 95,290 | 80,801 | 80,801 |
| End Cash Position | 19,841 | 88,385 | 113,200 | 95,290 | 70,924 |
| Net Cash Flow | $-75,449 | $-6,905 | $17,910 | $14,489 | $-9,877 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,918 | -55,014 | -28,601 | -98,122 | -71,545 |
| Capital Expenditure | -845 | -796 | -228 | -1,572 | -1,509 |
| Free Cash Flow | -79,763 | -55,810 | -28,829 | -99,694 | -73,054 |